{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:49:30Z","timestamp":1790801370313,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growing evidence suggests that peripheral factors to the brain driving neuro-inflammation could affect Alzheimer\u2019s Disease (AD) and Parkinson\u2019s Disease (PD) severity. Herpes simplex virus type 1 (HSV1) infection has been associated with AD while other related viruses, including cytomegalovirus (CMV), Epstein-Bar virus and human herpesvirus 6 (HHV6), are known to infect neurons. Here we compare gene expression profiles between AD or PD patients to those afflicted with herpes viral infections as to discover novel potential neuro-inflammation pathways. We found multiple significant differentially expressed genes (DEGs) shared between AD\/PD and viral infections including <jats:italic>SESN3<\/jats:italic> which has a genetic association for increased AD risk. Pathway enrichment analysis revealed viruses shared Oxidative Stress Defense System and LRRK2 pathways with AD and PD, respectively. We further processed our data to identify novel target and drug-repurposing opportunities including anti-inflammatory therapy, immune-modulators and cholinesterase inhibitors which could lead to new therapeutics paradigms for these neurodegenerative diseases.<\/jats:p>","DOI":"10.1038\/s41598-019-45129-8","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T12:04:56Z","timestamp":1560945896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses"],"prefix":"10.1038","volume":"9","author":[{"given":"Ana Caroline","family":"Costa Sa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-627X","authenticated-orcid":false,"given":"James R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"45129_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","volume":"348","author":"RL Nussbaum","year":"2003","unstructured":"Nussbaum, R. L. & Ellis, C. E. Alzheimer\u2019s disease and Parkinson\u2019s disease. N Engl J Med 348, 1356\u20131364, https:\/\/doi.org\/10.1056\/NEJM2003ra020003 (2003).","journal-title":"N Engl J Med"},{"key":"45129_CR2","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat Rev Dis Primers 1, 15056, https:\/\/doi.org\/10.1038\/nrdp.2015.56 (2015).","journal-title":"Nat Rev Dis Primers"},{"key":"45129_CR3","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat Rev Dis Primers 3, 17013, https:\/\/doi.org\/10.1038\/nrdp.2017.13 (2017).","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 1","key":"45129_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-1017057","volume":"21","author":"R Zimmer","year":"1988","unstructured":"Zimmer, R. & Lauter, H. Diagnosis, differential diagnosis and nosologic classification of the dementia syndrome. Pharmacopsychiatry 21(Suppl 1), 1\u20137, https:\/\/doi.org\/10.1055\/s-2007-1017057 (1988).","journal-title":"Pharmacopsychiatry"},{"key":"45129_CR5","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1096\/fj.201700360","volume":"31","author":"RF Itzhaki","year":"2017","unstructured":"Itzhaki, R. F. Herpes simplex virus type 1 and Alzheimer\u2019s disease: possible mechanisms and signposts. FASEB J 31, 3216\u20133226, https:\/\/doi.org\/10.1096\/fj.201700360 (2017).","journal-title":"FASEB J"},{"key":"45129_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","volume":"61","author":"F Song","year":"2009","unstructured":"Song, F., Poljak, A., Smythe, G. A. & Sachdev, P. Plasma biomarkers for mild cognitive impairment and Alzheimer\u2019s disease. Brain Res Rev 61, 69\u201380, https:\/\/doi.org\/10.1016\/j.brainresrev.2009.05.003 (2009).","journal-title":"Brain Res Rev"},{"key":"45129_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza, T. H. et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease. Nat Genet 42, 781\u2013785, https:\/\/doi.org\/10.1038\/ng.642 (2010).","journal-title":"Nat Genet"},{"key":"45129_CR8","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tins.2006.06.002","volume":"29","author":"AN van den Pol","year":"2006","unstructured":"van den Pol, A. N. Viral infections in the developing and mature brain. Trends Neurosci 29, 398\u2013406, https:\/\/doi.org\/10.1016\/j.tins.2006.06.002 (2006).","journal-title":"Trends Neurosci"},{"key":"45129_CR9","doi-asserted-by":"publisher","first-page":"121ps123","DOI":"10.1126\/scitranslmed.3003492","volume":"4","author":"M Deleidi","year":"2012","unstructured":"Deleidi, M. & Isacson, O. Viral and inflammatory triggers of neurodegenerative diseases. Sci Transl Med 4, 121ps123, https:\/\/doi.org\/10.1126\/scitranslmed.3003492 (2012).","journal-title":"Sci Transl Med"},{"key":"45129_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","volume":"565","author":"AM Colangelo","year":"2014","unstructured":"Colangelo, A. M., Alberghina, L. & Papa, M. Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci Lett 565, 59\u201364, https:\/\/doi.org\/10.1016\/j.neulet.2014.01.014 (2014).","journal-title":"Neurosci Lett"},{"key":"45129_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/13550280903296353","volume":"15","author":"G Henderson","year":"2009","unstructured":"Henderson, G., Jaber, T., Carpenter, D., Wechsler, S. L. & Jones, C. Identification of herpes simplex virus type 1 proteins encoded within the first 1.5 kb of the latency-associated transcript. J Neurovirol 15, 439\u2013448, https:\/\/doi.org\/10.3109\/13550280903296353 (2009).","journal-title":"J Neurovirol"},{"key":"45129_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-4933-7-16","volume":"7","author":"E Porcellini","year":"2010","unstructured":"Porcellini, E., Carbone, I., Ianni, M. & Licastro, F. Alzheimer\u2019s disease gene signature says: beware of brain viral infections. Immun Ageing 7, 16, https:\/\/doi.org\/10.1186\/1742-4933-7-16 (2010).","journal-title":"Immun Ageing"},{"key":"45129_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fneur.2017.00040","volume":"8","author":"G Westman","year":"2017","unstructured":"Westman, G. et al. Decreased HHV-6 IgG in Alzheimer\u2019s Disease. Front Neurol 8, 40, https:\/\/doi.org\/10.3389\/fneur.2017.00040 (2017).","journal-title":"Front Neurol"},{"key":"45129_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2013.06.024","volume":"35","author":"I Carbone","year":"2014","unstructured":"Carbone, I. et al. Herpes virus in Alzheimer\u2019s disease: relation to progression of the disease. Neurobiol Aging 35, 122\u2013129, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.06.024 (2014).","journal-title":"Neurobiol Aging"},{"key":"45129_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/1673-5374.226380","volume":"13","author":"JM Hogestyn","year":"2018","unstructured":"Hogestyn, J. M., Mock, D. J. & Mayer-Proschel, M. Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. Neural Regen Res 13, 211\u2013221, https:\/\/doi.org\/10.4103\/1673-5374.226380 (2018).","journal-title":"Neural Regen Res"},{"key":"45129_CR16","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijbiomac.2015.01.003","volume":"74","author":"M Wozniak","year":"2015","unstructured":"Wozniak, M., Bell, T., Denes, A., Falshaw, R. & Itzhaki, R. Anti-HSV1 activity of brown algal polysaccharides and possible relevance to the treatment of Alzheimer\u2019s disease. Int J Biol Macromol 74, 530\u2013540, https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.01.003 (2015).","journal-title":"Int J Biol Macromol"},{"key":"45129_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","volume":"46","author":"G De Chiara","year":"2012","unstructured":"De Chiara, G. et al. Infectious agents and neurodegeneration. Mol Neurobiol 46, 614\u2013638, https:\/\/doi.org\/10.1007\/s12035-012-8320-7 (2012).","journal-title":"Mol Neurobiol"},{"key":"45129_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0750-x","volume":"16","author":"S Sood","year":"2015","unstructured":"Sood, S. et al. A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status. Genome Biol 16, 185, https:\/\/doi.org\/10.1186\/s13059-015-0750-x (2015).","journal-title":"Genome Biol"},{"key":"45129_CR19","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1212\/WNL.0000000000004516","volume":"89","author":"R Shamir","year":"2017","unstructured":"Shamir, R. et al. Analysis of blood-based gene expression in idiopathic Parkinson disease. Neurology 89, 1676\u20131683, https:\/\/doi.org\/10.1212\/WNL.0000000000004516 (2017).","journal-title":"Neurology"},{"key":"45129_CR20","doi-asserted-by":"publisher","unstructured":"Riou, R. et al. Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses. J Virol 91, https:\/\/doi.org\/10.1128\/JVI.02245-16 (2017).","DOI":"10.1128\/JVI.02245-16"},{"key":"45129_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","volume":"8","author":"PA Nikitin","year":"2010","unstructured":"Nikitin, P. A. et al. An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8, 510\u2013522, https:\/\/doi.org\/10.1016\/j.chom.2010.11.004 (2010).","journal-title":"Cell Host Microbe"},{"key":"45129_CR22","doi-asserted-by":"publisher","first-page":"e64868","DOI":"10.1371\/journal.pone.0064868","volume":"8","author":"N Smith","year":"2013","unstructured":"Smith, N. et al. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation. PLoS One 8, e64868, https:\/\/doi.org\/10.1371\/journal.pone.0064868 (2013).","journal-title":"PLoS One"},{"key":"45129_CR23","doi-asserted-by":"publisher","first-page":"12792","DOI":"10.1073\/pnas.1302968110","volume":"110","author":"X Hu","year":"2013","unstructured":"Hu, X., Yu, J., Crosby, S. D. & Storch, G. A. Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci USA 110, 12792\u201312797, https:\/\/doi.org\/10.1073\/pnas.1302968110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"45129_CR24","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1242\/jcs.092098","volume":"125","author":"J Hagenbuchner","year":"2012","unstructured":"Hagenbuchner, J. et al. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125, 1191\u20131203, https:\/\/doi.org\/10.1242\/jcs.092098 (2012).","journal-title":"J Cell Sci"},{"key":"45129_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7031","volume":"6","author":"MR Johnson","year":"2015","unstructured":"Johnson, M. R. et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat Commun 6, 6031, https:\/\/doi.org\/10.1038\/ncomms7031 (2015).","journal-title":"Nat Commun"},{"key":"45129_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2014.00012","volume":"8","author":"BM Campbell","year":"2014","unstructured":"Campbell, B. M., Charych, E., Lee, A. W. & Moller, T. Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 8, 12, https:\/\/doi.org\/10.3389\/fnins.2014.00012 (2014).","journal-title":"Front Neurosci"},{"key":"45129_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O. & Cullen, K. M. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol Appl Neurobiol 31, 395\u2013404, https:\/\/doi.org\/10.1111\/j.1365-2990.2005.00655.x (2005).","journal-title":"Neuropathol Appl Neurobiol"},{"key":"45129_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s007020050029","volume":"107","author":"B Widner","year":"2000","unstructured":"Widner, B. et al. Tryptophan degradation and immune activation in Alzheimer\u2019s disease. J Neural Transm (Vienna) 107, 343\u2013353, https:\/\/doi.org\/10.1007\/s007020050029 (2000).","journal-title":"J Neural Transm (Vienna)"},{"key":"45129_CR29","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","volume":"267","author":"ES Arner","year":"2000","unstructured":"Arner, E. S. & Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267, 6102\u20136109 (2000).","journal-title":"Eur J Biochem"},{"key":"45129_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-131814","volume":"39","author":"L Arodin","year":"2014","unstructured":"Arodin, L. et al. Alteration of thioredoxin and glutaredoxin in the progression of Alzheimer\u2019s disease. J Alzheimers Dis 39, 787\u2013797, https:\/\/doi.org\/10.3233\/JAD-131814 (2014).","journal-title":"J Alzheimers Dis"},{"key":"45129_CR31","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","volume":"27","author":"DV Venkitaramani","year":"2007","unstructured":"Venkitaramani, D. V. et al. Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci 27, 11832\u201311837, https:\/\/doi.org\/10.1523\/JNEUROSCI.3478-07.2007 (2007).","journal-title":"J Neurosci"},{"key":"45129_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","volume":"16","author":"WP Arend","year":"1998","unstructured":"Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16, 27\u201355, https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.27 (1998).","journal-title":"Annu Rev Immunol"},{"key":"45129_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.febslet.2004.03.070","volume":"567","author":"J Dzwonek","year":"2004","unstructured":"Dzwonek, J., Rylski, M. & Kaczmarek, L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett 567, 129\u2013135, https:\/\/doi.org\/10.1016\/j.febslet.2004.03.070 (2004).","journal-title":"FEBS Lett"},{"key":"45129_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7, 583\u2013590, https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0 (2008).","journal-title":"Lancet Neurol"},{"key":"45129_CR35","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 102, 16842\u201316847, https:\/\/doi.org\/10.1073\/pnas.0507360102 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"45129_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2014.09.049","volume":"302","author":"J Schapansky","year":"2015","unstructured":"Schapansky, J., Nardozzi, J. D. & LaVoie, M. J. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson\u2019s disease. Neuroscience 302, 74\u201388, https:\/\/doi.org\/10.1016\/j.neuroscience.2014.09.049 (2015).","journal-title":"Neuroscience"},{"key":"45129_CR37","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1210\/jc.2007-0979","volume":"92","author":"EC Kaizer","year":"2007","unstructured":"Kaizer, E. C. et al. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 92, 3705\u20133711, https:\/\/doi.org\/10.1210\/jc.2007-0979 (2007).","journal-title":"J Clin Endocrinol Metab"},{"key":"45129_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-11-r127","volume":"10","author":"R Pankla","year":"2009","unstructured":"Pankla, R. et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol 10, R127, https:\/\/doi.org\/10.1186\/gb-2009-10-11-r127 (2009).","journal-title":"Genome Biol"},{"key":"45129_CR39","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/hmg\/ddt176","volume":"22","author":"JM Lee","year":"2013","unstructured":"Lee, J. M. et al. Dominant effects of the Huntington\u2019s disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy. Hum Mol Genet 22, 3227\u20133238, https:\/\/doi.org\/10.1093\/hmg\/ddt176 (2013).","journal-title":"Hum Mol Genet"},{"key":"45129_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nn.4597","volume":"20","author":"TF Galatro","year":"2017","unstructured":"Galatro, T. F. et al. Transcriptomic analysis of purified human cortical microglia reveals age-associated changes. Nat Neurosci 20, 1162\u20131171, https:\/\/doi.org\/10.1038\/nn.4597 (2017).","journal-title":"Nat Neurosci"},{"key":"45129_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat Genet 47, 856\u2013860, https:\/\/doi.org\/10.1038\/ng.3314 (2015).","journal-title":"Nat Genet"},{"key":"45129_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1046\/j.1471-4159.2002.00871.x","volume":"81","author":"JO Rinne","year":"2002","unstructured":"Rinne, J. O. et al. Increased brain histamine levels in Parkinson\u2019s disease but not in multiple system atrophy. J Neurochem 81, 954\u2013960 (2002).","journal-title":"J Neurochem"},{"key":"45129_CR43","doi-asserted-by":"publisher","first-page":"e4147","DOI":"10.1097\/MD.0000000000004147","volume":"95","author":"FJ Jimenez-Jimenez","year":"2016","unstructured":"Jimenez-Jimenez, F. J., Alonso-Navarro, H., Garcia-Martin, E. & Agundez, J. A. Thr105Ile (rs11558538) polymorphism in the histamine N-methyltransferase (HNMT) gene and risk for Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 95, e4147, https:\/\/doi.org\/10.1097\/MD.0000000000004147 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"45129_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.21037\/atm.2018.04.11","volume":"6","author":"XX Chen","year":"2018","unstructured":"Chen, X. X. et al. The impact of GAB2 genetic variations on cerebrospinal fluid markers in Alzheimer\u2019s disease. Ann Transl Med 6, 171, https:\/\/doi.org\/10.21037\/atm.2018.04.11 (2018).","journal-title":"Ann Transl Med"},{"key":"45129_CR45","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935, https:\/\/doi.org\/10.1126\/science.1132939 (2006).","journal-title":"Science"},{"key":"45129_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1517\/14656566.3.4.365","volume":"3","author":"PP Zandi","year":"2002","unstructured":"Zandi, P. P., Breitner, J. C. & Anthony, J. C. Is pharmacological prevention of Alzheimer\u2019s a realistic goal? Expert Opin Pharmacother 3, 365\u2013380, https:\/\/doi.org\/10.1517\/14656566.3.4.365 (2002).","journal-title":"Expert Opin Pharmacother"},{"key":"45129_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(12)70259-4","volume":"12","author":"K Bettens","year":"2013","unstructured":"Bettens, K., Sleegers, K. & Van Broeckhoven, C. Genetic insights in Alzheimer\u2019s disease. Lancet Neurol 12, 92\u2013104, https:\/\/doi.org\/10.1016\/S1474-4422(12)70259-4 (2013).","journal-title":"Lancet Neurol"},{"key":"45129_CR48","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912, https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3 (2015).","journal-title":"Lancet"},{"key":"45129_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1126\/science.aao4426","volume":"359","author":"MA Lodato","year":"2018","unstructured":"Lodato, M. A. et al. Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359, 555\u2013559, https:\/\/doi.org\/10.1126\/science.aao4426 (2018).","journal-title":"Science"},{"key":"45129_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2014.38","volume":"10","author":"VH Perry","year":"2014","unstructured":"Perry, V. H. & Holmes, C. Microglial priming in neurodegenerative disease. Nat Rev Neurol 10, 217\u2013224, https:\/\/doi.org\/10.1038\/nrneurol.2014.38 (2014).","journal-title":"Nat Rev Neurol"},{"key":"45129_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","volume":"302","author":"CH Latta","year":"2015","unstructured":"Latta, C. H., Brothers, H. M. & Wilcock, D. M. Neuroinflammation in Alzheimer\u2019s disease; A source of heterogeneity and target for personalized therapy. Neuroscience 302, 103\u2013111, https:\/\/doi.org\/10.1016\/j.neuroscience.2014.09.061 (2015).","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"45129_CR52","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","volume":"20","author":"LM Chahine","year":"2014","unstructured":"Chahine, L. M., Stern, M. B. & Chen-Plotkin, A. Blood-based biomarkers for Parkinson\u2019s disease. Parkinsonism Relat Disord 20(Suppl 1), S99\u2013103, https:\/\/doi.org\/10.1016\/S1353-8020(13)70025-7 (2014).","journal-title":"Parkinsonism Relat Disord"},{"key":"45129_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-2009-0996","volume":"16","author":"E Grunblatt","year":"2009","unstructured":"Grunblatt, E. et al. Gene expression as peripheral biomarkers for sporadic Alzheimer\u2019s disease. J Alzheimers Dis 16, 627\u2013634, https:\/\/doi.org\/10.3233\/JAD-2009-0996 (2009).","journal-title":"J Alzheimers Dis"},{"key":"45129_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.lab.2005.10.005","volume":"147","author":"CC Liew","year":"2006","unstructured":"Liew, C. C., Ma, J., Tang, H. C., Zheng, R. & Dempsey, A. A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147, 126\u2013132, https:\/\/doi.org\/10.1016\/j.lab.2005.10.005 (2006).","journal-title":"J Lab Clin Med"},{"key":"45129_CR55","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2006.08.004","volume":"28","author":"OC Maes","year":"2007","unstructured":"Maes, O. C. et al. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28, 1795\u20131809, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.08.004 (2007).","journal-title":"Neurobiol Aging"},{"key":"45129_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.b.30272","volume":"141B","author":"PF Sullivan","year":"2006","unstructured":"Sullivan, P. F., Fan, C. & Perou, C. M. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B, 261\u2013268, https:\/\/doi.org\/10.1002\/ajmg.b.30272 (2006).","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"45129_CR57","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2013.03.016","volume":"17","author":"R Wang","year":"2013","unstructured":"Wang, R. et al. Metabolic stress modulates Alzheimer\u2019s beta-secretase gene transcription via SIRT1-PPARgamma-PGC-1 in neurons. Cell Metab 17, 685\u2013694, https:\/\/doi.org\/10.1016\/j.cmet.2013.03.016 (2013).","journal-title":"Cell Metab"},{"key":"45129_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg, G. A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8, 205\u2013216, https:\/\/doi.org\/10.1016\/S1474-4422(09)70016-X (2009).","journal-title":"Lancet Neurol"},{"key":"45129_CR59","doi-asserted-by":"publisher","first-page":"e1006500","DOI":"10.1371\/journal.ppat.1006500","volume":"13","author":"Y Pei","year":"2017","unstructured":"Pei, Y., Banerjee, S., Jha, H. C., Sun, Z. & Robertson, E. S. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation. PLoS Pathog 13, e1006500, https:\/\/doi.org\/10.1371\/journal.ppat.1006500 (2017).","journal-title":"PLoS Pathog"},{"key":"45129_CR60","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41, 1308\u20131312, https:\/\/doi.org\/10.1038\/ng.487 (2009).","journal-title":"Nat Genet"},{"key":"45129_CR61","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601\u2013607, https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005 (2004).","journal-title":"Neuron"},{"key":"45129_CR62","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1212\/01.wnl.0000304044.22253.03","volume":"70","author":"K Haugarvoll","year":"2008","unstructured":"Haugarvoll, K. et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology 70, 1456\u20131460, https:\/\/doi.org\/10.1212\/01.wnl.0000304044.22253.03 (2008).","journal-title":"Neurology"},{"key":"45129_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5483\/BMBRep.2015.48.5.032","volume":"48","author":"JR Bae","year":"2015","unstructured":"Bae, J. R. & Lee, B. D. Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson\u2019s disease and beyond. BMB Rep 48, 243\u2013248 (2015).","journal-title":"BMB Rep"},{"key":"45129_CR64","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","volume":"118","author":"M Hakimi","year":"2011","unstructured":"Hakimi, M. et al. Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm (Vienna) 118, 795\u2013808, https:\/\/doi.org\/10.1007\/s00702-011-0653-2 (2011).","journal-title":"J Neural Transm (Vienna)"},{"key":"45129_CR65","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet, A. et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol 185, 5577\u20135585, https:\/\/doi.org\/10.4049\/jimmunol.1000548 (2010).","journal-title":"J Immunol"},{"key":"45129_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12918-017-0524-z","volume":"12","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Arat, S., Magid-Slav, M. & Brown, J. R. Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets. BMC Syst Biol 12, 3, https:\/\/doi.org\/10.1186\/s12918-017-0524-z (2018).","journal-title":"BMC Syst Biol"},{"key":"45129_CR67","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/ni.2113","volume":"12","author":"Z Liu","year":"2011","unstructured":"Liu, Z. et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol 12, 1063\u20131070, https:\/\/doi.org\/10.1038\/ni.2113 (2011).","journal-title":"Nat Immunol"},{"key":"45129_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2015.10.006","volume":"26","author":"KE Olson","year":"2016","unstructured":"Olson, K. E. & Gendelman, H. E. Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson\u2019s disease. Curr Opin Pharmacol 26, 87\u201395, https:\/\/doi.org\/10.1016\/j.coph.2015.10.006 (2016).","journal-title":"Curr Opin Pharmacol"},{"key":"45129_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","volume":"97","author":"Y Xu","year":"2012","unstructured":"Xu, Y. et al. Neurotransmitter receptors and cognitive dysfunction in Alzheimer\u2019s disease and Parkinson\u2019s disease. Prog Neurobiol 97, 1\u201313, https:\/\/doi.org\/10.1016\/j.pneurobio.2012.02.002 (2012).","journal-title":"Prog Neurobiol"},{"key":"45129_CR70","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4088\/JCP.13m08927","volume":"75","author":"N Ayutyanont","year":"2014","unstructured":"Ayutyanont, N. et al. The Alzheimer\u2019s prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer\u2019s disease treatments in presenilin 1 E280A mutation carriers. J Clin Psychiatry 75, 652\u2013660, https:\/\/doi.org\/10.4088\/JCP.13m08927 (2014).","journal-title":"J Clin Psychiatry"},{"key":"45129_CR71","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1602\/neurorx.1.1.117","volume":"1","author":"FM Longo","year":"2004","unstructured":"Longo, F. M. & Massa, S. M. Neuroprotective strategies in Alzheimer\u2019s disease. NeuroRx 1, 117\u2013127, https:\/\/doi.org\/10.1602\/neurorx.1.1.117 (2004).","journal-title":"NeuroRx"},{"key":"45129_CR72","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2014.03.009","volume":"11","author":"A-FR Group","year":"2015","unstructured":"Group, A.-F. R. Follow-up evaluation of cognitive function in the randomized Alzheimer\u2019s Disease Anti-inflammatory Prevention Trial and its Follow-up Study. Alzheimers Dement 11, 216\u2013225 e211, https:\/\/doi.org\/10.1016\/j.jalz.2014.03.009 (2015).","journal-title":"Alzheimers Dement"},{"key":"45129_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2017.10.019","volume":"63","author":"D Mastroeni","year":"2018","unstructured":"Mastroeni, D. et al. Laser-captured microglia in the Alzheimer\u2019s and Parkinson\u2019s brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer\u2019s brain. Neurobiol Aging 63, 12\u201321, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.10.019 (2018).","journal-title":"Neurobiol Aging"},{"key":"45129_CR74","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jalz.2014.04.522","volume":"11","author":"H Lovheim","year":"2015","unstructured":"Lovheim, H., Gilthorpe, J., Adolfsson, R., Nilsson, L. G. & Elgh, F. Reactivated herpes simplex infection increases the risk of Alzheimer\u2019s disease. Alzheimers Dement 11, 593\u2013599, https:\/\/doi.org\/10.1016\/j.jalz.2014.04.522 (2015).","journal-title":"Alzheimers Dement"},{"key":"45129_CR75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jalz.2014.07.157","volume":"11","author":"H Lovheim","year":"2015","unstructured":"Lovheim, H. et al. Herpes simplex infection and the risk of Alzheimer\u2019s disease: A nested case-control study. Alzheimers Dement 11, 587\u2013592, https:\/\/doi.org\/10.1016\/j.jalz.2014.07.157 (2015).","journal-title":"Alzheimers Dement"},{"key":"45129_CR76","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-161305","volume":"61","author":"H Lovheim","year":"2018","unstructured":"Lovheim, H. et al. Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer\u2019s Disease Development. J Alzheimers Dis 61, 939\u2013945, https:\/\/doi.org\/10.3233\/JAD-161305 (2018).","journal-title":"J Alzheimers Dis"},{"key":"45129_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.05.023","author":"B Readhead","year":"2018","unstructured":"Readhead, B. et al. Multiscale Analysis of Independent Alzheimer\u2019s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2018.05.023 (2018).","journal-title":"Neuron"},{"key":"45129_CR78","doi-asserted-by":"publisher","first-page":"e75607","DOI":"10.1371\/journal.pone.0075607","volume":"8","author":"SB Smith","year":"2013","unstructured":"Smith, S. B., Magid-Slav, M. & Brown, J. R. Host response to respiratory bacterial pathogens as identified by integrated analysis of human gene expression data. PLoS One 8, e75607, https:\/\/doi.org\/10.1371\/journal.pone.0075607 (2013).","journal-title":"PLoS One"},{"key":"45129_CR79","doi-asserted-by":"publisher","first-page":"e33174","DOI":"10.1371\/journal.pone.0033174","volume":"7","author":"SB Smith","year":"2012","unstructured":"Smith, S. B., Dampier, W., Tozeren, A., Brown, J. R. & Magid-Slav, M. Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis. PLoS One 7, e33174, https:\/\/doi.org\/10.1371\/journal.pone.0033174 (2012).","journal-title":"PLoS One"},{"key":"45129_CR80","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2017","unstructured":"Koscielny, G. et al. Open Targets: a platform for therapeutic target identification and validation. Nucleic Acids Res 45, D985\u2013D994, https:\/\/doi.org\/10.1093\/nar\/gkw1055 (2017).","journal-title":"Nucleic Acids Res"},{"key":"45129_CR81","unstructured":"Andrews, S. FastQC: A Quality Control tool for High Throughput Sequence Data. Available online at https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"45129_CR82","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321, https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"45129_CR83","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930, https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"45129_CR84","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc 4, 1184\u20131191, https:\/\/doi.org\/10.1038\/nprot.2009.97 (2009).","journal-title":"Nat Protoc"},{"key":"45129_CR85","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.1093\/nar\/gkv352","volume":"43","author":"M Davies","year":"2015","unstructured":"Davies, M. et al. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res 43, W612\u2013620, https:\/\/doi.org\/10.1093\/nar\/gkv352 (2015).","journal-title":"Nucleic Acids Res"},{"key":"45129_CR86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar, A. & Singh, A. & Ekavali. A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67, 195\u2013203, https:\/\/doi.org\/10.1016\/j.pharep.2014.09.004 (2015).","journal-title":"Pharmacol Rep"},{"key":"45129_CR87","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00002093-200001000-00005","volume":"14","author":"JP Blass","year":"2000","unstructured":"Blass, J. P., Cyrus, P. A., Bieber, F. & Gulanski, B. Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group. Alzheimer Dis Assoc Disord 14, 39\u201345 (2000).","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"45129_CR88","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2174\/1381612820666140826114601","volume":"21","author":"PR Heckman","year":"2015","unstructured":"Heckman, P. R., Wouters, C. & Prickaerts, J. Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer\u2019s disease: a translational overview. Curr Pharm Des 21, 317\u2013331 (2015).","journal-title":"Curr Pharm Des"},{"key":"45129_CR89","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3233\/JAD-141875","volume":"43","author":"YL Lan","year":"2015","unstructured":"Lan, Y. L., Zhao, J. & Li, S. Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer\u2019s disease. J Alzheimers Dis 43, 1137\u20131148, https:\/\/doi.org\/10.3233\/JAD-141875 (2015).","journal-title":"J Alzheimers Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45129-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:37:37Z","timestamp":1671273457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45129"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45129-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.C.C.S., H.M. and J.R.B. were employees of GlaxoSmithKline at the time of this study, and H.M. and J.R.B. are company shareholders. There are no other financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8795"}}